bigd...I agree with you that xkem is in its infancy and money has to be plowed back into R&D and clinical tests until revenue and growth history are established. When this happens, then they can do a buy-back to reduce the number of outstanding shares and increase the pps so we can move to a major exchange.
It is not mandatory to do an R/S before moving to a major exchange. I would like to move to a major exchange with all my shares intact. Personally, I see r/s as a gimmick to rob shareholders. lol.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.